Most Active Stocks

COCHINSHIP
BSE
SCI
INDIGO
JUBLINGREA
GRSE
BEL
HAL
RELIANCE
MAZDOCK
CDSL
ONGC
RPOWER
OIL
BDL
HDFCBANK
GESHIP
SBIN
INFY
ICICIBANK

Zydus Lifesciences Limited

Drug Manufacturers - Specialty & Generic | Healthcare

Company Overview

Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally. It operates through two segments: Pharmaceuticals and Consumer Products. It offers finished dosage human formulations, such as generics; branded generics; specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; animal healthcare products; and products in the therapeutic areas of pain management, neurology, metabolic disorder, and liver diseases. The company provides the products under the Everyuth, Nutralite, SugarFree, Complan, Glucon-D, and Nycil brands. In addition, the company offers a pipeline of biological products in the areas of oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology, and infectious illnesses. Further, it engages in the investment, animal health and veterinary, pharmacy retail, and manpower supply and administration activities. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is headquartered in Ahmedabad, India. Zydus Lifesciences Limited is a subsidiary of Zydus Family Trust.

Key Information

Market Cap

989425958912

Current Price

983.3

52 Week Range

795.0 - 1324.3

Previous Close

981.8

Open

985.0

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Contact Details

Address

Zydus Corporate Park, Scheme No. 63 Survey No. 536, Khoraj (Gandhinagar) Near Vaishnodevi Circle, Sarkhej Gandhinagar Highw, Ahmedabad, 382481, India

Phone

+91-79480-40000

Fax

+91-79268-68337

Website

https://zyduslife.com

Financials

Day Low

982.05

Day High

992.45

Dividend Yield

1.13

PE Ratio

21.677689

Earnings Per Share

45.36

Beta

0.482

EBITDA

68950999040

Book Value

238.119

EPS

45.11575

Company Officers

Name Title Age Year Born
Dr. Sharvil Pankajbhai Patel MD & Executive Director 45 1979
Dr. Ganesh Narayan Nayak COO & Executive Director 69 1955
Mr. Punit Patel President & CEO of America - -
Mr. Nitinkumar Dalsukhray Parekh Chief Financial Officer - -
Mr. Arvind Bothra Head of Investor Relations - -
Mr. Dhaval Narendra Soni Company Secretary & Compliance Officer - -
Mr. Vikram Shukla President of Parenteral Operations 50 1974
Mr. Tushar Dhansukh Shroff President of Finance - -

Company Details

Stock History

Explore More Stocks